Swiss Nuclides’ CHF 2.6 Million Series A Financing Round

Vischer assisted Swiss Nuclides in this transaction . Swiss Nuclides AG, a developer of novel radionuclide PET tracers for the precision diagnostics, has raised CHF 2.6m…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now